Tae Jun Lee

Tae Jun Lee

Auto-generated profile, based on publicly available information

Tae Jun Lee

Department of Ophthalmology and Visual Sciences, Washington University School of Medicine

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2020 in eLife
Verified
Journal Article
Open access
YSYo Sasaki
Yo Sasaki
HKHiroki Kakita
Hiroki Kakita
SKShunsuke Kubota
Shunsuke Kubota
ASAbdoulaye Sene
Abdoulaye Sene
TLTae Jun Lee
Tae Jun Lee
JMJeffrey Milbrandt
Jeffrey Milbrandt
Leber congenital amaurosis type nine is an autosomal recessive retinopathy caused by mutations of the NAD+ synthesis enzyme NMNAT1. Despite the ubiquitous expression of NMNAT1, patients do not manifest pathologies other than retinal degeneration. Here we demonstrate that widespread NMNAT1 depletion in adult mice mirrors the human pathology, with selective loss of photoreceptors highlighting the exquisite vulnerability of these cells to NMNAT1 loss. Conditional deletion demonstrates that NMNAT1 is required within the photoreceptor. Mechanistically, loss of NMNAT1 activates the NADase SARM1, the central executioner of axon degeneration, to trigger photoreceptor death and vision loss. Hence, the essential function of NMNAT1 in photoreceptors is to inhibit SARM1, highlighting an unexpected shared mechanism between axonal degeneration and photoreceptor neurodegeneration. These results define a novel SARM1-dependent photoreceptor cell death pathway and identifies SARM1 as a therapeutic candidate for retinopathies.

6 September 2018 in JCI Insight
Verified
Journal Article
Open access
PDF file
NBNorimitsu Ban
Norimitsu Ban
TLTae Jun Lee
Tae Jun Lee
ASAbdoulaye Sene
Abdoulaye Sene
MCMayur Choudhary
Mayur Choudhary
MLMichael Lekwuwa
Michael Lekwuwa
RARajendra S. Apte
Rajendra S. Apte
Advanced age-related macular degeneration (AMD), the leading cause of blindness among people over 50 years of age, is characterized by atrophic neurodegeneration or pathologic angiogenesis. Early AMD is characterized by extracellular cholesterol-rich deposits underneath the retinal pigment epithelium (RPE) called drusen or in the subretinal space called subretinal drusenoid deposits (SDD) that drive disease progression. However, mechanisms of drusen and SDD biogenesis remain poorly understood. Although human AMD is characterized by abnormalities in cholesterol homeostasis and shares phenotypic features with atherosclerosis, it is unclear whether systemic immunity or local tissue metabolism regulates this homeostasis. Here, we demonstrate that targeted deletion of macrophage cholesterol ABC transporters A1 (ABCA1) and -G1 (ABCG1) leads to age-associated extracellular cholesterol-rich deposits underneath the neurosensory retina similar to SDD seen in early human AMD. These mice also develop impaired dark adaptation, a cardinal feature of RPE cell dysfunction seen in human AMD patients even before central vision is affected. Subretinal deposits in these mice progressively worsen with age, with concomitant accumulation of cholesterol metabolites including several oxysterols and cholesterol esters causing lipotoxicity that manifests as photoreceptor dysfunction and neurodegeneration. These findings suggest that impaired macrophage cholesterol transport initiates several key elements of early human AMD, demonstrating the importance of systemic immunity and aging in promoting disease manifestation. Polymorphisms in genes involved with cholesterol transport and homeostasis are associated with a significantly higher risk of developing AMD, thus making these studies translationally relevant by identifying potential targets for therapy.

1 October 2019 in Experimental Eye Research
Verified
Journal Article
Closed access
ZDZhenyu Dong
Zhenyu Dong
ASAndrea Santeford
Andrea Santeford
NBNorimitsu Ban
Norimitsu Ban
TLTae Jun Lee
Tae Jun Lee
CSCraig Smith
Craig Smith
RARajendra S. Apte
Rajendra S. Apte

1 August 2018 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
NBNorimitsu Ban
Norimitsu Ban
TLTae Jun Lee
Tae Jun Lee
ASAbdoulaye Sene
Abdoulaye Sene
ZDZhenyu Dong
Zhenyu Dong
ASAndrea Santeford
Andrea Santeford
RARajendra S. Apte
Rajendra S. Apte
Photoreceptors have high intrinsic metabolic demand and are exquisitely sensitive to metabolic perturbation. In addition, they shed a large portion of their outer segment lipid membranes in a circadian manner, increasing the metabolic burden on the outer retina associated with the re-synthesis of cell membranes and disposal of the cellular cargo. Here we demonstrate that deletion of both ABCA1 and ABCG1 in rod photoreceptors leads to age-related accumulation of cholesterol metabolites in the outer retina, photoreceptor dysfunction, degeneration of rod outer segments, and ultimately blindness. A high fat diet (HFD) significantly accelerates rod neurodegeneration and vision loss, further highlighting the role of lipid homeostasis in regulating photoreceptor neurodegeneration and vision.

24 June 2025 in Nature Communications
Verified
Journal Article
Open access
TLTae Jun Lee
Tae Jun Lee
ASAndrea Santeford
Andrea Santeford
KPKristen M. Pitts
Kristen M. Pitts
CRCarla Valenzuela Ripoll
Carla Valenzuela Ripoll
RTRyo Terao
Ryo Terao
RARajendra S. Apte
Rajendra S. Apte
Age-related macular degeneration (AMD) is a leading cause of blindness in people over 50. AMD and cardiovascular disease share risk factors including age, impaired lipid metabolism, and extracellular lipid deposition. Because of its importance in age-related diseases, we hypothesize that apolipoprotein M (ApoM), a lipocalin that binds sphingosine-1-phosphate (S1P), might restore lipid homeostasis and retinal function in AMD. In support, we find that human patients with AMD demonstrate significantly reduced ApoM compared to controls. In mice with impaired retinal cholesterol efflux, ApoM improves retinal pigment epithelium (RPE) function and lipotoxicity in an S1P- and S1P receptor 3-dependent manner. Ultrastructural evidence of enhanced melanosome-lipid droplet interactions led us to hypothesize and demonstrate that ApoM-S1P signaling drives RPE-specific lysosomal lipid catabolism. RPE-specific knockout of lysosomal acid lipase recapitulates features of AMD. Our study defines a novel role for ApoM/S1P signaling in AMD driven by RPE lipotoxicity, mediated by cell-autonomous lysosomal lipid catabolism.

16 January 2024 in JCI Insight
Verified
Journal Article
Open access
PDF file
TLTae Jun Lee
Tae Jun Lee
YSYo Sasaki
Yo Sasaki
PRPhilip A. Ruzycki
Philip A. Ruzycki
NBNorimitsu Ban
Norimitsu Ban
JLJoseph B. Lin
Joseph B. Lin
RARajendra S. Apte
Rajendra S. Apte
AMP-activated protein kinase (AMPK) plays a crucial role in maintaining ATP homeostasis in photoreceptor neurons. AMPK is a heterotrimeric protein consisting of α, β, and γ subunits. The independent functions of the 2 isoforms of the catalytic α subunit, PRKAA1 and PRKAA2, are uncharacterized in specialized neurons, such as photoreceptors. Here, we demonstrate in mice that rod photoreceptors lacking PRKAA2, but not PRKAA1, showed altered levels of cGMP, GTP, and ATP, suggesting isoform-specific regulation of photoreceptor metabolism. Furthermore, PRKAA2-deficient mice displayed visual functional deficits on electroretinography and photoreceptor outer segment structural abnormalities on transmission electron microscopy consistent with neuronal dysfunction, but not neurodegeneration. Phosphoproteomics identified inosine monophosphate dehydrogenase (IMPDH) as a molecular driver of PRKAA2-specific photoreceptor dysfunction, and inhibition of IMPDH improved visual function in Prkaa2 rod photoreceptor–knockout mice. These findings highlight a therapeutically targetable PRKAA2 isoform–specific function of AMPK in regulating photoreceptor metabolism and function through a potentially previously uncharacterized mechanism affecting IMPDH activity.